Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Crispr Therapeutics AG (CRSP) vs Walmart Stores Inc (WMT) Price & Performance

Crispr Therapeutics AGTrade
Walmart Stores IncTrade

Price performance (Past 24H)

Key statistics

Crispr Therapeutics AG vs Walmart Stores Inc — how do they compare? Crispr Therapeutics AG trades at $53.88 (market cap $5.17B), while Walmart Stores Inc trades at $112.95 (market cap $896.56B). The key difference: Walmart Stores Inc is far larger — about 173.4× Crispr Therapeutics AG's market cap, and Walmart Stores Inc pays a 0.88% dividend while Crispr Therapeutics AG pays none. Which is the better fit depends on your goals.

CRSPWMT
Market Cap
$5.17B$896.56B
Sector
HealthConsumer Staples
52-Week High
$76.78$134.20
52-Week Low
$44.34$96.05
Enterprise Value
$3.59B$960.01B
Volume
5,675,288
Dividend Yield
0.88%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Crispr Therapeutics AG

No Aura AI signal available yet.

Walmart Stores Inc

Walmart (WMT) stock trades at $113.26, up 1.26% today, with a neutral technical signal and strong analyst consensus. The company demonstrates robust fundamentals with revenue growth to $681.0B in 2025 and net income of $19.4B, alongside consistent earnings beats. Recent news highlights operational innovations like drone delivery expansion and AI tools, while maintaining a solid dividend.

Outlook remains positive with a $142 consensus price target, though risks include competitive pressures and margin sustainability. The stock presents a long-term opportunity given its defensive positioning and growth initiatives, but investors should monitor execution against Amazon and consumer spending trends.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Crispr Therapeutics AG

CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.

Read more on CRSP

About Walmart Stores Inc

Walmart Inc. operates discount stores, supercenters, and neighborhood markets. The Company offers merchandise such as apparel, house wares, small appliances, electronics, musical instruments, books, home improvement, shoes, jewelry, toddler, games, household essentials, pets, pharmaceutical products, party supplies, and automotive tools. Walmart serves customers worldwide.

Read more on WMT